We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
268 result(s) found, displaying 71 to 80
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for IMBRUVICA ibrutinib 560 mg film-coated tablet blister.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for IMBRUVICA ibrutinib 420 mg film-coated tablet blister.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for IMBRUVICA ibrutinib 140 mg film-coated tablet blister.
-
Prescription medicine decision summaryTGA decision: Ponvory (ponesimod) is approved to treat relapsing forms of multiple sclerosis.
-
Designation or determinationProvisional determination
-
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TREMFYA guselkumab 100 mg solution for injection pre-filled pen (One-Press (R) patient controlled injector).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Janssen-Cilag Pty Ltd - Electric infusion pump administration set.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SYMTUZA 800/150/200/10 darunavir/cobicistat/emtricitabine/tenofovir alafenamide 800/150/200/10 mg film-coated tablets.
-
Prescription medicine registrationActive ingredients: daratumumab.